Compagnie Lombard Odier S Cm A Pfizer Inc Transaction History

Compagnie Lombard Odier S Cm A

$5.66 Billion
Q2 2024

A detailed history of Compagnie Lombard Odier S Cm A transactions in Pfizer Inc stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 457,226 shares of PFE stock, worth $13.3 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

457,226

Previous 379,306 20.54%

Holding current value

$13.3 Million

Previous $10.5 Million 21.55%

% of portfolio

0.23%

Previous 0.2%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$25.26 - $29.6 $1.97 Million - $2.31 Million	77,920 Added 20.54%	457,226 $12.8 Million
Q1 2024 May 01, 2024	BUY	$25.89 - $29.73 $3.33 Million - $3.82 Million	128,651 Added 51.33%	379,306 $10.5 Million
Q4 2023 Jan 16, 2024	BUY	$26.13 - $33.94 $4.94 Million - $6.42 Million	189,223 Added 308.02%	250,655 $7.22 Million
Q3 2023 Oct 23, 2023	SELL	$32.09 - $37.51 $1.02 Million - $1.19 Million	-31,680 Reduced 34.02%	61,432 $2.04 Million
Q2 2023 Aug 07, 2023	BUY	$36.12 - $41.79 $901,808 - $1.04 Million	24,967 Added 36.64%	93,112 $3.42 Million
Q1 2023 May 01, 2023	SELL	$39.39 - $51.28 $191,474 - $249,272	-4,861 Reduced 6.66%	68,145 $2.78 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $129,550 - $169,113	3,103 Added 4.44%	73,006 $3.74 Million
Q3 2022 Nov 09, 2022	SELL	$43.76 - $53.42 $94,740 - $115,654	-2,165 Reduced 3.0%	69,903 $3.06 Million
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $126,561 - $150,062	-2,720 Reduced 3.64%	72,068 $3.78 Million
Q1 2022 Apr 27, 2022	SELL	$45.75 - $56.69 $722,987 - $895,872	-15,803 Reduced 17.44%	74,788 $3.87 Million
Q4 2021 Feb 09, 2022	SELL	$41.32 - $61.25 $60,988 - $90,405	-1,476 Reduced 1.6%	90,591 $5.35 Million
Q3 2021 Oct 28, 2021	SELL	$39.25 - $50.42 $399,408 - $513,073	-10,176 Reduced 9.95%	92,067 $3.97 Million
Q2 2021 Jul 15, 2021	BUY	$35.91 - $40.68 $460,007 - $521,110	12,810 Added 14.32%	102,243 $4.01 Million
Q1 2021 Apr 23, 2021	SELL	$33.49 - $37.77 $1.08 Million - $1.22 Million	-32,187 Reduced 26.47%	89,433 $3.24 Million
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $2.39 Million - $3.04 Million	71,385 Added 142.1%	121,620 $4.48 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $371,157 - $435,452	11,690 Added 30.33%	50,235 $1.84 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $150,600 - $182,700	-5,000 Reduced 11.48%	38,545 $1.26 Million
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $249,432 - $356,385	9,228 Added 26.89%	43,545 $1.42 Million
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $32,920 - $37,360	-1,000 Reduced 2.83%	34,317 $1.35 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $29,241 - $37,917	900 Added 2.61%	35,317 $1.27 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $37,571 - $42,184	-1,016 Reduced 2.87%	34,417 $1.49 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $5.28 Million - $5.8 Million	-140,706 Reduced 79.88%	35,433 $1.5 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $119,295 - $136,009	-3,101 Reduced 1.73%	176,139 $7.69 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $15,339 - $18,605	445 Added 0.25%	179,240 $7.9 Million
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $15,170 - $16,173	-460 Reduced 0.26%	178,795 $6.49 Million
Q1 2018 May 11, 2018	SELL	$31.91 - $37.02 $181,344 - $210,384	-5,683 Reduced 3.07%	179,255 $6.36 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $295,215 - $313,234	-8,876 Reduced 4.58%	184,938 $6.7 Million
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $85,405 - $94,083	-2,755 Reduced 1.4%	193,814 $6.92 Million
Q2 2017 Aug 14, 2017	BUY	N/A	196,569	196,569 $6.61 Million

Others Institutions Holding PFE

# of Institutions

3,220

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $163B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

News

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.

Account

Compagnie Lombard Odier S Cm A Pfizer Inc Transaction History